Dual-Target CAR-T Therapy: A Breakthrough for Aggressive Brain Tumors

Researchers at McMaster University have developed a new immunotherapy strategy that simultaneously attacks glioblastoma tumors and the immune cells that help them grow. By using Chimeric Antigen Receptor T-cell (CAR-T) therapy to target the GPNMB protein, the study—published July 1 in Nature—demonstrated the ability to eliminate detectable tumors and achieve long-term disease-free survival in pre-clinical … Read more

New CellTrap Tech Reveals How Immune Cells Attack Brain Tumors

Researchers at the Technical University of Munich (TUM) have developed a microfluidic platform, dubbed CellTrap, that allows for the observation of individual immune cell-to-cancer cell interactions in real time. By trapping single cells within a network of 1,024 micro-chambers, the system enables researchers to track the precise timing, activation, and lethal impact of immune cells … Read more

Cytokine-armored CAR-T cell therapy successfully attacks aggressive brain tumors in mice

Beyond Blood Cancers: The New Frontier of Solid Tumor Therapy For years, CAR-T cell therapy has been hailed as a miracle for certain blood cancers, but solid tumors—particularly aggressive brain cancers like glioblastoma—have remained stubbornly resistant. The challenge isn’t just the cancer itself, but the “shield” these tumors build around themselves to hide from the … Read more

Scientists Discover Testosterone Could Actually Protect Against Deadly Brain Cancer

The Testosterone Paradox: A New Frontier in Glioblastoma Treatment For decades, the medical community has viewed androgens—specifically testosterone—with suspicion in the context of oncology. In many cases, such as prostate cancer, testosterone acts as fuel for the fire, prompting doctors to use androgen deprivation therapy to starve tumors. However, a groundbreaking study from the Cleveland … Read more

Next-generation cancer therapy shows early promise as treatment candidate for glioblastoma

Breaking the Deadlock: The New Frontier in Glioblastoma Treatment For more than twenty years, the standard of care for glioblastoma—the most common and aggressive primary brain cancer in adults—has remained largely stagnant. Despite the combined efforts of surgery, radiation, and chemotherapy, this disease remains uniformly fatal, often recurring rapidly after treatment. However, recent preclinical research … Read more

Grandad with brain cancer thought headaches were sleep apnea | Health

From Headaches to Heartbreak: A Nottingham Family’s Battle with Glioblastoma Andrew Hayes, a 61-year-old from Nottingham, initially dismissed his headaches as a symptom of sleep apnoea. This common misdiagnosis highlights a critical challenge in early cancer detection – the subtlety of initial symptoms. It wasn’t until severe head pain prompted a visit to Queen’s Medical … Read more

Woman Suffered from What She Thought Were ‘Chronic Migraines.’ After a Visit to the Doctor, Everything Changed (Exclusive)

From Migraines to Miracles: The Future of Glioblastoma Treatment For Becca Valle, what began as seemingly chronic migraines turned into a harrowing glioblastoma diagnosis. Her story, and others like it, are driving a revolution in how we approach this aggressive brain cancer. While glioblastoma remains a formidable challenge – with a dismal five-year survival rate … Read more

‘Hidden vulnerability’ involving vitamin B uncovered in aggressive brain cancer

Brain Cancer Breakthrough: Diet and Vitamin B3 Offer New Hope for Glioblastoma Patients Scientists have identified a significant “hidden vulnerability” in glioblastoma, an aggressive form of brain cancer, opening the door to potential new treatment strategies. Research published in the journal Science Advances suggests that a combination of prescribed diet and existing steroid anti-inflammatory drugs … Read more

Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment

The Future of Glioblastoma Treatment: Harnessing the Immune System and Personalized Medicine A $40,000 grant awarded to researchers at the University of Cincinnati Cancer Center marks a significant step forward in the fight against glioblastoma, one of the most aggressive and deadly forms of brain cancer. The project, funded by Ride Cincinnati, focuses on a … Read more

New breakthrough could modernize treatment for glioblastoma

A New Dawn for Glioblastoma Treatment: Combining Chemotherapy with a Surprising Ally For decades, glioblastoma, one of the most aggressive forms of brain cancer, has stubbornly resisted effective treatment. Survival rates remain grim – around 7% beyond five years post-diagnosis. But a groundbreaking study from the UNC School of Medicine and UNC Eshelman School of … Read more